Generate a tailored SOP for Dr. Martin Turner. Improve your application with a focused, well-structured draft.
Martin Turner completed his undergraduate studies in Biochemistry at University College London (UCL) before pursuing a PhD under the supervision of Marc Feldmann, focusing on the regulation of cytokine gene expression. His work contributed to the identification of TNF as a target for treating rheumatoid arthritis. After completing his PhD, he joined the Medical Research Council's National Institute for Medical Research (MRC-NIMR) where he collaborated with Victor Tybulewicz to uncover essential elements of signal transduction necessary for the development of lymphocytes. Since joining the Babraham Institute in 1997, Turner has continued his research in signal transduction, particularly identifying the roles of PI3K in lymphocyte development and activation. His work has informed the rationale for using PI3K delta inhibitors in human malignancies. His recent research investigates RNA-processing mechanisms that control the development and function of B T lymphocytes, focusing on RNA-binding proteins and microRNAs in signal transduction networks that regulate cell differentiation and immune responses. His laboratory is dedicated to understanding the mechanisms that drive lymphocyte development and activation, making significant strides in identifying RNA-binding proteins crucial to lymphocyte function.
Babraham Institute • Cambridge, UK
Conducting research on signal transduction and lymphocyte development.
Standard postgraduate requirements for Department of Politics and International Studies (POLIS) and related humanities departments.